0001179110-20-011053.txt : 20201112 0001179110-20-011053.hdr.sgml : 20201112 20201112171323 ACCESSION NUMBER: 0001179110-20-011053 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201110 FILED AS OF DATE: 20201112 DATE AS OF CHANGE: 20201112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Naylor Stuart CENTRAL INDEX KEY: 0001742771 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38520 FILM NUMBER: 201307966 MAIL ADDRESS: STREET 1: C/O MEIRAGTX - US STREET 2: 430 EAST 29TH STREET, 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MeiraGTx Holdings plc CENTRAL INDEX KEY: 0001735438 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 450 EAST 29TH STREET STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 6464902965 MAIL ADDRESS: STREET 1: 450 EAST 29TH STREET STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 4 1 edgar.xml FORM 4 - X0306 4 2020-11-10 0 0001735438 MeiraGTx Holdings plc MGTX 0001742771 Naylor Stuart 450 EAST 29TH STREET, 14TH FLOOR NEW YORK NY 10016 0 1 0 0 Chief Development Officer Ordinary Shares 2020-11-10 4 S 0 3739 15.00 D 451129 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.01, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. /s/ Richard Giroux, Attorney-in-Fact for Stuart Naylor 2020-11-12